Transplant community perceptions of the benefits and drawbacks of alternative quality metrics for regulation.
Sarah E Van Pilsum RasmussenSheng ZhouAlvin G ThomasDorry L SegevLauren H NicholasPublished in: Clinical transplantation (2019)
Despite previously published concerns with existing regulatory metrics, most participants did not believe any metrics would outperform one-year patient and graft survival.